granted
on 28 Mar 2024
Last Applicant/ Owned by
106 W 32nd St, 2nd floor
New York
NY
10001
Serial Number
97084528 filed on 20th Oct 2021
Registration Number
N/A
Correspondent Address
Brendan J. Hughes
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Biopharmaceutical research and development services in the field of neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system diseases and disorders; research and development services in the field of pharmaceuticals and treatments for neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system disorders and diseases The English tRead More
Biopharmaceutical research and development services in the field of neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system diseases and disorders; research and development services in the field of pharmaceuticals and treatments for neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system disorders and diseases
Pharmaceutical preparations for the treatment, prognosis, and diagnosis of neurological, neurodegenerative, neurodevelopmental, psychiatric, and central nervous system diseases and disorders
No 97084528
No Service Mark
No 340412-20000
No
No
No
No
No
No
No
No
| Status Date | Action Taken |
|---|---|
| 29th Mar 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 28th Mar 2024 | SOU TEAS EXTENSION RECEIVED |
| 28th Mar 2024 | SOU EXTENSION 1 FILED |
| 28th Mar 2024 | SOU EXTENSION 1 GRANTED |
| 03rd Oct 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 08th Aug 2023 | PUBLISHED FOR OPPOSITION |
| 08th Aug 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 19th Jul 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 03rd Jul 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 29th Jun 2023 | ASSIGNED TO LIE |
